Researchers identify why CAR T therapy may fail in some lymphoma patients
Chimeric antigen receptor T-cell therapy, or CAR T, has been a breakthrough in the treatment of blood cancers such as acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Clinical studies have shown overall response ...
Feb 2, 2021
0
2